On June 29, 2026, sixty-three insiders at Hinge Health, Inc. (HNGE) executed sales of company stock, totaling approximately $939.30 million. The transactions involved various entities, including Holdings Group, Llc, Venture Partners X. (Co-Investors), L.P., Venture Partners (Delaware) X, L.P., Venture Partners (Cayman) X, L.P., Venture Partners X, L.P., and Venture Associates X, Ltd.
These sales occurred at prices ranging from $71.59 to $84.02 per share. While insider selling can be attributed to a variety of reasons such as portfolio diversification, tax obligations, or personal financial needs, the large volume and number of insiders involved in this coordinated activity may be of interest to market observers.
Hinge Health, Inc. operates in the digital health sector, focusing on providing solutions for musculoskeletal care. The company's stock has experienced significant trading activity following these insider transactions.